Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

CMPX Q2 2018 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CMPXCompass Therapeutics, Inc.

$764M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$0

Net Income

$0

EPS (Diluted)

$0.00

Cash Flow

Operating Cash Flow

-$7,894

Free Cash Flow

-$7,894

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$7,231

Total Liabilities

$50,257

Stockholders' Equity

-$43,026

Cash & Equivalents

$7,231

← FY 2018 All Quarters Q1 2019 →